Premium
Hexyl‐5‐aminolaevulinate 0·2% vs. methyl‐5‐aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double‐blinded pilot trial
Author(s) -
NeittaanmäkiPerttu N.,
Grönroos M.,
Karppinen T.T.,
Tani T.T.,
Snellman E.
Publication year - 2016
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.13924
Subject(s) - actinic keratoses , dermatology , medicine , photodynamic therapy , double blinded , randomized controlled trial , daylight , chemistry , pathology , basal cell , optics , physics , alternative medicine , organic chemistry , placebo
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom